Research record

Late-life semaglutide treatment slows ageing and extends lifespan in female mice.

Preclinical research, indexed because it matched monitored longevity research terms. Inclusion in this index does not establish that an intervention is effective or safe.

Published
September 2, 2026
Authors
Feng Y, Barthez M, Wang Y, Chen Y, Qiu H, Wang CL, Heydari K, Delcroix M, Rasmussen LJ, Bohr VA, Chen D.
DOI
10.1038/s41586-026-10940-7
Evidence class
preclinical
Record status
published
Match confidence
75%
Citations
0
Source feed
Europe PMC
Automated source synopsis

Preclinical research, indexed because it matched monitored longevity research terms. Inclusion in this index does not establish that an intervention is effective or safe.

Why this record matched · 75% confidence

Published automatically with 75% topic confidence after controlled-term evaluation.

  • GLP-1 therapies · 75%Legacy record evaluated automatically against controlled title and longevity-context rules.

Source quality 90% · freshness 100%. These are automated routing signals, not medical or evidence-strength ratings.

BibTeX · RIS

glp 1 therapies
Open primary sourceExport JSON